Lainscak M - Search Results

1

Sarcopenia: A Time for Action. An SCWD Position Paper.

Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, Baracos VE, Crawford JA, Doehner W, Heymsfield SB, Jatoi A, Kalantar-Zadeh K, Lainscak M, Landi F, Laviano A, Mancuso M, Muscaritoli M, Prado CM, Strasser F, von Haehling S, Coats AJS, Anker SD. Bauer J, et al. Among authors: lainscak m. J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):956-961. doi: 10.1002/jcsm.12483. Epub 2019 Sep 15. J Cachexia Sarcopenia Muscle. 2019. PMID: 31523937 Free PMC article. Review.

2

Body composition changes in patients with systolic heart failure treated with beta blockers: a pilot study.

Lainscak M, Keber I, Anker SD. Lainscak M, et al. Int J Cardiol. 2006 Jan 26;106(3):319-22. doi: 10.1016/j.ijcard.2005.01.061. Int J Cardiol. 2006. PMID: 16337039

3

Metabolic disturbances in chronic heart failure: a case for the "macho" approach with testosterone?!

Lainscak M, Doehner W, Anker SD. Lainscak M, et al. Eur J Heart Fail. 2007 Jan;9(1):2-3. doi: 10.1016/j.ejheart.2006.07.006. Epub 2006 Oct 5. Eur J Heart Fail. 2007. PMID: 17027336 Free article.

4

Biomarkers for chronic heart failure.

Lainscak M, von Haehling S, Springer J, Anker SD. Lainscak M, et al. Heart Fail Monit. 2007;5(3):77-82. Heart Fail Monit. 2007. PMID: 17487296 Review.

5

Atrial natriuretic peptide and related peptides.

Akashi YJ, Springer J, Lainscak M, Anker SD. Akashi YJ, et al. Among authors: lainscak m. Clin Chem Lab Med. 2007;45(10):1259-67. doi: 10.1515/CCLM.2007.274. Clin Chem Lab Med. 2007. PMID: 17663625 Review.

6

Sibutramine in cardiovascular disease: is SCOUT the new STORM on the horizon?

von Haehling S, Lainscak M, Anker SD. von Haehling S, et al. Among authors: lainscak m. Eur Heart J. 2007 Dec;28(23):2830-1. doi: 10.1093/eurheartj/ehm493. Epub 2007 Nov 5. Eur Heart J. 2007. PMID: 17984134 No abstract available.

7

Atrial fibrillation in chronic non-cardiac disease: where do we stand?

Lainscak M, Dagres N, Filippatos GS, Anker SD, Kremastinos DT. Lainscak M, et al. Int J Cardiol. 2008 Aug 29;128(3):311-5. doi: 10.1016/j.ijcard.2007.12.078. Epub 2008 Mar 28. Int J Cardiol. 2008. PMID: 18374999 Review.

8

Cachexia: common, deadly, with an urgent need for precise definition and new therapies.

Lainscak M, Filippatos GS, Gheorghiade M, Fonarow GC, Anker SD. Lainscak M, et al. Am J Cardiol. 2008 Jun 2;101(11A):8E-10E. doi: 10.1016/j.amjcard.2008.02.065. Am J Cardiol. 2008. PMID: 18514632

9

How does cachexia influence survival in cancer, heart failure and other chronic diseases?

Lainscak M, Podbregar M, Anker SD. Lainscak M, et al. Curr Opin Support Palliat Care. 2007 Dec;1(4):299-305. doi: 10.1097/SPC.0b013e3282f31667. Curr Opin Support Palliat Care. 2007. PMID: 18685379 Review.

10

Cardiac cachexia: a systematic overview.

von Haehling S, Lainscak M, Springer J, Anker SD. von Haehling S, et al. Among authors: lainscak m. Pharmacol Ther. 2009 Mar;121(3):227-52. doi: 10.1016/j.pharmthera.2008.09.009. Epub 2008 Nov 14. Pharmacol Ther. 2009. PMID: 19061914 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

318 results

Search Page